WTA
RVMD icon

Washington Trust Advisors’s Revolution Medicines RVMD Stock Holding History

Washington Trust Advisors’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$90.3K Buy
+482
New +$70.4K 0.01% 301
2025
Q4 		– Sell
-64
Closed -$2.99K – 678
2025
Q3 		$2.99K Buy
+64
New +$2.51K ﹤0.01% 646

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Washington Trust Advisors's RVMD Position: Q2 2026 in Review

Washington Trust Advisors opened a new position in Revolution Medicines (RVMD) in Q2 2026: 482 shares worth $90.3K. The stake represents 0.01% of the portfolio and ranks #301 among its holdings. This is a return to the name: Washington Trust Advisors previously reported a position in RVMD as recently as Q3 2025.

Washington Trust Advisors first reported a position in RVMD in Q3 2025 and has held it in 2 quarters since. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Washington Trust Advisors held 482 shares of Revolution Medicines worth $90.3K as of Q2 2026.
  • Revolution Medicines was a new Washington Trust Advisors position in Q2 2026.
  • Revolution Medicines made up 0.01% of Washington Trust Advisors's portfolio in Q2 2026, its #301 holding.
  • Washington Trust Advisors first reported a position in Revolution Medicines in Q3 2025 and has held it in 2 quarters since.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.